SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 136.70 |
Enterprise Value ($M) | 131.99 |
Book Value ($M) | -12.59 |
Book Value / Share | -0.26 |
Price / Book | -10.86 |
NCAV ($M) | -12.59 |
NCAV / Share | -0.26 |
Price / NCAV | -10.86 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | -8.64 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.29 |
Current Ratio | 0.29 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 5.18 |
Assets | 5.18 |
Liabilities | 17.77 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Fortress Biotech, Inc. | |||
13G/A | Armistice Capital, Llc | 9.99 | 68.42 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
162,322 | 504,689 | 32.16 | |
127,465 | 496,858 | 25.65 | |
158,358 | 457,499 | 34.61 | |
88,527 | 409,878 | 21.60 | |
164,180 | 617,210 | 26.60 | |
(click for more detail) |
Similar Companies | |
---|---|
CELZ – Creative Medical Technology Holdings, Inc. | CGEN – Compugen Ltd. |
CING – Cingulate Inc. | CLDX – Celldex Therapeutics, Inc. |
CLNN – Clene Inc. |
Financial data and stock pages provided by
Fintel.io